AP2012006303A0 - Anti-trypanosomiasis vaccines and diagnostics. - Google Patents

Anti-trypanosomiasis vaccines and diagnostics.

Info

Publication number
AP2012006303A0
AP2012006303A0 AP2012006303A AP2012006303A AP2012006303A0 AP 2012006303 A0 AP2012006303 A0 AP 2012006303A0 AP 2012006303 A AP2012006303 A AP 2012006303A AP 2012006303 A AP2012006303 A AP 2012006303A AP 2012006303 A0 AP2012006303 A0 AP 2012006303A0
Authority
AP
ARIPO
Prior art keywords
trypanosomiasis
vaccines
diagnostics
trypanosomiasis vaccines
Prior art date
Application number
AP2012006303A
Other languages
English (en)
Inventor
Linares Virginie Coustou
Nicolas Plazolles
Theo Baltz
Original Assignee
Univ Bordeaux Segalen
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bordeaux Segalen, Centre Nat Rech Scient filed Critical Univ Bordeaux Segalen
Publication of AP2012006303A0 publication Critical patent/AP2012006303A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AP2012006303A 2009-11-10 2010-11-10 Anti-trypanosomiasis vaccines and diagnostics. AP2012006303A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0957953A FR2952382B1 (fr) 2009-11-10 2009-11-10 Vaccins et diagnostics contre les trypanosomoses animales africaines
PCT/EP2010/067245 WO2011058080A1 (fr) 2009-11-10 2010-11-10 Vaccins et diagnostics contre les trypanosomoses

Publications (1)

Publication Number Publication Date
AP2012006303A0 true AP2012006303A0 (en) 2012-06-30

Family

ID=42170832

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2012006303A AP2012006303A0 (en) 2009-11-10 2010-11-10 Anti-trypanosomiasis vaccines and diagnostics.

Country Status (12)

Country Link
US (1) US20120276131A1 (fr)
EP (1) EP2499244A1 (fr)
CN (1) CN102858963A (fr)
AP (1) AP2012006303A0 (fr)
AU (1) AU2010317992A1 (fr)
BR (1) BR112012011009A2 (fr)
CA (1) CA2779076A1 (fr)
CO (2) CO6551742A2 (fr)
FR (1) FR2952382B1 (fr)
MX (1) MX2012005406A (fr)
WO (1) WO2011058080A1 (fr)
ZA (1) ZA201203412B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9744220B2 (en) 2013-03-14 2017-08-29 Tufts University Compositions and methods for treating inflammatory diseases
BR112015025951A2 (pt) * 2013-04-12 2017-10-17 Univ Danmarks Tekniske sialidase mutante com atividade trans-sialidase, para uso em produção de glicanos sialilados
CN103278642A (zh) * 2013-05-15 2013-09-04 广西大学 一种检测伊氏锥虫vsg抗原的双抗体夹心酶联免疫吸附测定试剂盒及制备方法
BR112017028052A2 (pt) * 2015-06-23 2018-09-11 Epivax Inc peptídeo, método para induzir uma resposta imune em um sujeito e formulação de vacina
RU2686695C1 (ru) * 2017-11-27 2019-04-30 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени Я.Р. Коваленко" (ФГБНУ ВИЭВ) Способ дифференциальной диагностики случной болезни (t. equiperdum) и сурры (t. evansi) лошадей

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR958035A (fr) 1950-03-02
WO1995029699A1 (fr) * 1994-04-29 1995-11-09 Curtis Powell Vaccin, procede de determination diagnostique et procede de traitement des protozoaires hemoflagelles parasites
TNSN97045A1 (fr) * 1996-03-12 2005-03-15 Sovarec Sa Histones de trypanosomatides, genes et derives de genes les codant, construction d'adn, vecteur, organismes hote, tests et vaccins correspondants, et leur utilisation.
WO2002019960A2 (fr) 2000-09-06 2002-03-14 Pays, Etienne Purification, caracterisation et utilisation de structures antigeniques protectrices contre des trypanosomes et des parasites apparentes
DE10258400A1 (de) * 2002-12-13 2004-06-24 N.V. Nutricia Trans-Sialidasen aus Trypanosoma congolense
JP4553354B2 (ja) * 2004-10-04 2010-09-29 正隆 井原 抗トリパノソーマ剤
MX2008011632A (es) 2006-03-17 2008-10-17 Vib Vzw Vacuna novedosa contra infeccion de trypanosoma cruzi.
CA2685558A1 (fr) 2007-04-28 2008-11-06 Fraunhofer Usa, Inc. Antigenes de trypanosome, compositions de vaccins et procedes associes

Also Published As

Publication number Publication date
CA2779076A1 (fr) 2011-05-19
CN102858963A (zh) 2013-01-02
MX2012005406A (es) 2013-02-27
FR2952382B1 (fr) 2011-11-25
FR2952382A1 (fr) 2011-05-13
AU2010317992A1 (en) 2012-06-21
EP2499244A1 (fr) 2012-09-19
US20120276131A1 (en) 2012-11-01
BR112012011009A2 (pt) 2016-11-29
ZA201203412B (en) 2013-07-31
CO6551742A2 (es) 2012-10-31
CO6551741A2 (es) 2012-10-31
WO2011058080A1 (fr) 2011-05-19

Similar Documents

Publication Publication Date Title
GB0905570D0 (en) Combined vaccines
ZA201109164B (en) Vaccine
ZA201202363B (en) Mycobacterial vaccines
IL208660A0 (en) Coccididosis vaccines
EP2408473A4 (fr) Procédés de vaccination
GB0906234D0 (en) Vaccine
EP2491946A4 (fr) Adjuvant pour vaccins, vaccins le comprenant, et ses utilisations
GB0907935D0 (en) Vaccines
ZA201203412B (en) Anti-trypanosomiasis vaccines and diagnostics
AP2011005894A0 (en) 5-alkynyl-pyridines.
HK1173661A1 (zh) 納米乳劑疫苗
AP2011006000A0 (en) Fermentation.
GB201000522D0 (en) Vaccine
GB0801326D0 (en) Vaccines
GB2476715B (en) Eco-F.E.W.L.
EP2411039A4 (fr) Vaccins glycoconjugués
EP2243102A4 (fr) Attributs d'imagerie à inversion dans le temps
GB0904239D0 (en) Seating
IL217194A0 (en) Vaccine
GB0904238D0 (en) Seating
AP2011005899A0 (en) Plaswall.
GB0917644D0 (en) An equine visual aid
GB0909144D0 (en) Vaccines
GB0909147D0 (en) Vaccines
GB0909146D0 (en) Vaccines